Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
NGNE Neurogene
- 16.935
- -0.115-0.67%
Trading Mar 11 09:51 ET
251.56MMarket Cap-5.98P/E (TTM)
17.190High16.760Low4.99KVolume17.060Open17.050Pre Close84.54KTurnover0.09%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High1.83P/B91.11MFloat Cap14.42052wk Low--Dividend TTM5.38MShs Float1115.000Historical High--Div YieldTTM2.52%Amplitude7.500Historical Low16.945Avg Price1Lot Size
About Neurogene Company
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
Company Profile
SymbolNGNE
Company NameNeurogene
Listing DateMar 7, 2014
Founded2007
CEOMr. Richard K. Matros
MarketNASDAQ
Employees91
Fiscal Year Ends12-31
Address535 West 24th Street,5th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10011
Phone1-877-237-5020
Websitehttp://www.neurogene.com
Company Executives
- Name
- Position
- Salary
- Dr. Rachel McMinn, PhD
- Executive Chairman of the Board and Chief Executive Officer
- 1.08M
- Dr. Stuart Cobb, PhD
- Chief Scientific Officer
- 784.32K
- Christine Mikail Cvijic, J.D.
- President and Chief Financial Officer
- 1.13M
- Dr. Julie Jordan, M.D.
- Chief Medical Officer
- --
- Donna Cochener
- Senior Vice President and General Counsel
- --
- Rohan Palekar
- Independent Director
- 71.62K
- Dr. Cory Freedland, PhD
- Independent Director
- --
- Dr. Robert A. Baffi,PhD
- Independent Director
- 64.08K
- Robert Keith Woods
- Independent Director
- --
- Dr. Sarah B. Noonberg, M.D.,PhD
- Independent Director
- 62.12K